These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 10840398)

  • 41. Gabapentin anticonvulsant action in rats: disequilibrium with peak drug concentrations in plasma and brain microdialysate.
    Welty DF; Schielke GP; Vartanian MG; Taylor CP
    Epilepsy Res; 1993 Dec; 16(3):175-81. PubMed ID: 8119268
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gabapentin: discussion.
    Fromm GH
    Epilepsia; 1994; 35 Suppl 5():S77-80. PubMed ID: 8039476
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tiagabine synergistically interacts with gabapentin in the electroconvulsive threshold test in mice.
    Luszczki JJ; Swiader M; Parada-Turska J; Czuczwar SJ
    Neuropsychopharmacology; 2003 Oct; 28(10):1817-30. PubMed ID: 12865900
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brain.
    Löscher W; Hönack D; Taylor CP
    Neurosci Lett; 1991 Jul; 128(2):150-4. PubMed ID: 1945036
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Seizure frequency and CSF parameters in a double-blind placebo controlled trial of gabapentin in patients with intractable complex partial seizures.
    Ben-Menachem E; Söderfelt B; Hamberger A; Hedner T; Persson LI
    Epilepsy Res; 1995 Jul; 21(3):231-6. PubMed ID: 8536677
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lack of interaction of gabapentin with carbamazepine or valproate.
    Radulovic LL; Wilder BJ; Leppik IE; Bockbrader HN; Chang T; Posvar EL; Sedman AJ; Uthman BM; Erdman GR
    Epilepsia; 1994; 35(1):155-61. PubMed ID: 8112239
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elevated homocarnosine and GABA in subject on isoniazid as assessed through 1H MRS at 7T.
    Landheer K; Prinsen H; Petroff OA; Rothman DL; Juchem C
    Anal Biochem; 2020 Jun; 599():113738. PubMed ID: 32302606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicentre, double-blind, placebo-controlled study. Gabapentin Paediatric Study Group.
    Appleton R; Fichtner K; LaMoreaux L; Alexander J; Halsall G; Murray G; Garofalo E
    Epilepsia; 1999 Aug; 40(8):1147-54. PubMed ID: 10448830
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gabapentin potentiation of the antiepileptic efficacy of vigabatrin in an in vitro model of epilepsy.
    Lücke A; Musshoff U; Köhling R; Osterfeld M; Mayer T; Wolf P; Schütte W; Speckmann EJ
    Br J Pharmacol; 1998 May; 124(2):370-6. PubMed ID: 9641555
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gabapentin actions on Kir3 currents and N-type Ca2+ channels via GABAB receptors in hippocampal pyramidal cells.
    Bertrand S; Nouel D; Morin F; Nagy F; Lacaille JC
    Synapse; 2003 Nov; 50(2):95-109. PubMed ID: 12923812
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systemic gabapentin and S(+)-3-isobutyl-gamma-aminobutyric acid block secondary hyperalgesia.
    Jones DL; Sorkin LS
    Brain Res; 1998 Nov; 810(1-2):93-9. PubMed ID: 9813259
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gabapentin as add-on therapy for refractory partial epilepsy: results of five placebo-controlled trials.
    Leiderman DB
    Epilepsia; 1994; 35 Suppl 5():S74-6. PubMed ID: 8039475
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gabapentin in childhood epilepsy: a prospective evaluation of efficacy and safety.
    Korn-Merker E; Borusiak P; Boenigk HE
    Epilepsy Res; 2000 Jan; 38(1):27-32. PubMed ID: 10604603
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vigabatrin, but not gabapentin or topiramate, produces concentration-related effects on enzymes and intermediates of the GABA shunt in rat brain and retina.
    Sills GJ; Butler E; Forrest G; Ratnaraj N; Patsalos PN; Brodie MJ
    Epilepsia; 2003 Jul; 44(7):886-92. PubMed ID: 12823570
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and tolerance of long-term, high-dose gabapentin: additional observations.
    Handforth A; Treiman DM
    Epilepsia; 1994; 35(5):1032-7. PubMed ID: 7925148
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anticonvulsant efficacy of gabapentin on kindling in the immature brain.
    Lado FA; Sperber EF; Moshé SL
    Epilepsia; 2001 Apr; 42(4):458-63. PubMed ID: 11440340
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures.
    Hosford DA; Wang Y
    Epilepsia; 1997 Apr; 38(4):408-14. PubMed ID: 9118845
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anticonvulsant action and long-term effects of gabapentin in the immature brain.
    Cilio MR; Bolanos AR; Liu Z; Schmid R; Yang Y; Stafstrom CE; Mikati MA; Holmes GL
    Neuropharmacology; 2001; 40(1):139-47. PubMed ID: 11077080
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gabapentin in the management of convulsive disorders.
    McLean MJ
    Epilepsia; 1999; 40 Suppl 6():S39-50; discussion S73-4. PubMed ID: 10530682
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gabapentin for treatment of epilepsy in children.
    Holmes GL
    Semin Pediatr Neurol; 1997 Sep; 4(3):244-50. PubMed ID: 9323792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.